Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.850
-0.010-0.21%
Volume:80.38M
Turnover:393.76M
Market Cap:55.99B
PE:9.14
High:5.000
Open:4.850
Low:4.810
Close:4.860
Loading ...

CSPC Pharmaceutical Group 9M Revenue RMB 22,686 Million

THOMSON REUTERS
·
15 Nov 2024

CSPC Pharmaceutical Gets Regulatory Go-Ahead to Conduct HPV Vaccine Trials in China

MT Newswires Live
·
12 Nov 2024

BRIEF-CSPC Pharmaceutical Says Bivalent HPV MRNA Therapeutic Vaccine Obtains Clinical Trial Approval

Reuters
·
12 Nov 2024

DIARY-Hong Kong corporate earnings week ahead

Reuters
·
08 Nov 2024

Stock Track | CSPC Pharmaceutical Shares Plummet After Profit Warning

Stock Track
·
01 Nov 2024

Greater China Stocks Close Mixed; Hong Kong Leads Gainers

Dow Jones
·
01 Nov 2024

CSPC Pharmaceutical Group Expects 16% Decline In January-September Profit; Shares Slide 8%

MT Newswires Live
·
01 Nov 2024

Stock Track | CSPC Pharmaceutical Shares Plunge on Weak Profit Outlook

Stock Track
·
01 Nov 2024

BUZZ-CSPC Pharmaceutical falls most in 10 weeks on weak earnings outlook

Reuters
·
01 Nov 2024

BRIEF-CSPC Pharmaceutical Sees Decrease In Profit Attributable Of 16% For Nine Months

Reuters
·
31 Oct 2024

CSPC Pharmaceutical - Expected Result Due to Decrease in Revenue of Finished Drugs Business

THOMSON REUTERS
·
31 Oct 2024

CSPC Pharmaceutical Sees Decrease in Profit Attributable of 16% for Nine Months

THOMSON REUTERS
·
31 Oct 2024

Bullish CSPC Pharmaceutical Group Insiders Loaded Up On CN¥39.6m Of Stock

Simply Wall St.
·
31 Oct 2024

CSPC Pharmaceutical's Myasthenia Gravis Drug Gets NMPA's Nod for Clinical Trial

MT Newswires Live
·
28 Oct 2024

BRIEF-CSPC Pharmaceutical Says First mRNA-LNP-Based CAR-T Cell Injection Obtains Further Clinical Trial Approval For New Indication

Reuters
·
25 Oct 2024

CSPC Pharmaceutical - Got Approval From Nmpa China

THOMSON REUTERS
·
25 Oct 2024